GNC Holdings (GNC) Tops Q4 Earnings, Lags Revenue Estimates

GNC Holdings, Inc. GNC reported fourth-quarter 2017 adjusted earnings per share (EPS) of 25 cents, reflecting a massive 257.1% year-over-year increase. Adjusted EPS also surpassed the Zacks Consensus Estimate by a penny.

Full-year 2017 adjusted EPS of $1.35, compared to $2.16 of 2016. Adjusted EPS also surpassed the Zacks Consensus Estimate of $1.29.


Revenues (which now exclude Lucky Vitamin in all periods) in the reported quarter dropped 2.1% year over year to $557.7 million. The figure also missed the Zacks Consensus Estimate of $558.4 million.

GNC Holdings, Inc. Price, Consensus and EPS Surprise

GNC Holdings, Inc. Price, Consensus and EPS Surprise | GNC Holdings, Inc. Quote

The company reported full-year revenues of $2.45 billion, compared with the year-ago $2.54 billion. The figure missed the Zacks Consensus Estimateof $2.46 billion.

Same-store sales increased 5.7% in domestic company-owned stores (including sales) in the quarter under review. In domestic franchise locations, same-store sales declined 2%.

Segments in Details

GNC Holdings reports operations under three segments: U.S. & Canada (including company-owned stores in the United States, Puerto Rico and Canada, franchise stores in the United States and e-commerce); International (including franchise locations in approximately 50 countries, The Health Store and China operations); and Manufacturing/Wholesale (comprising manufactured products sold to other segments, third-party contract manufacturing and sales to wholesale partners).

During the reported quarter, GNC Holdings' revenues from the U.S. & Canada segment inched up 1% to $456.2 million, primarily driven by the increase in same-store sales of 5.7% for company-owned stores, including, partially offset by the $12-million decrease due to the discontinuation of the Gold Card program in the United States and the introduction of loyalty programs. In domestic franchise locations as well, revenues declined 2.2% due to lower wholesale sales, including the impact of retail sales comp of negative 3%.

Revenues at the international segment increased 14.1% to $45.3 million driven by higher cross-border e-commerce sales in China.

Revenues at the manufacturing/wholesale segment (excluding intersegment revenues) declined 2.4% to $56.3 million. Within this segment, third-party contract manufacturing sales fell 1.4% to $33.4 million. Sales to wholesale partners decreased 3.8% year over year to $22.9 million in the quarter. However, Intersegment sales increased to $56.2 million from the year-ago $46.2 million on the company's increased focus on proprietary products.

After the asset sale of Lucky Vitamin on Sep 30, 2017, Lucky Vitamin is now included within Other segment for applicable prior periods to ensure comparability, which resulted in a $20.7-million drop in fourth-quarter revenues from the prior-year quarter.


Gross profit increased 4.3% in the reported quarter to $177.5 million. As a result, gross margin expanded 198 basis points (bps) to 31.8%.

Selling, general and administrative expenses contracted 4.7% to $137.9 million. Accordingly, adjusted operating margin expanded 264 bps to 7.1%.

Financial Position

GNC Holdings exited 2017 with cash and cash equivalents of $64 million, up from $34.5 million at the end of 2016. Long-term debt was $1.29 billion at the end of 2017, compared with $1.53 billion at 2016-end. Net cash flow from operating activities totaled $220.5 million, compared with $208.2 million a year ago.

Further, the company generated free cash flow of $196.7 million as compared with $185.8 million in the previous year.

One New GNC Plan Update

Earlier, management had announced plans to revamp its existing business model, dubbed as the 'One New GNC'. The company has been seeing transformational changes in the fourth quarter of 2017 as well. Transaction growth was up 11.7% in the fourth quarter. In 2017, more than 11 million consumers had joined the company's loyalty programs, including approximately 850,000 customers enrolled in the PRO Access membership.

Our Take

GNC Holdings exited the fourth quarter of 2017 on a mixed note. However, the year-over-year increase in adjusted earnings is encouraging. Also, the expansion in gross and adjusted operating margin is encouraging.

During the fourth quarter, management witnessed positive response for its New GNC Plan. The company has also been witnessing improvement in transactions and e-commerce business, which buoys optimism.

Zacks Rank & Key Picks

GNC Holdings has a Zacks Rank #3 (Hold).

A few better-ranked stocks that reported solid results this earnings season are PetMed Express PETS , PerkinElmer PKI and Becton, Dickinson and Company BDX . While PetMed sports a Zacks Rank #1 (Strong Buy), PerkinElmer and Becton, Dickinson carry a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank stocks here.

PetMed reported third-quarter fiscal 2018 adjusted earnings per share of 44 cents, up 88.3% from the prior-year quarter. Revenues rose 13.7% to $60.1 million.

PerkinElmer posted fourth-quarter 2017 adjusted earnings per share of 97 cents. Adjusted revenues were approximately $641.6 million, up from $567 million a year ago.

Becton, Dickinson reported first-quarter 2018 adjusted earnings per share of $2.48, up 3.9% at constant currency. Revenues totaled $3.08 billion, up 3.7% at constant currency.

Don't Even Think About Buying Bitcoin Until You Read This

The most popular cryptocurrency skyrocketed last year, giving some investors the chance to bank 20X returns or even more. Those gains, however, came with serious volatility and risk. Bitcoin sank 25% or more 3 times in 2017.

Zacks has just released a new Special Report to help readers capitalize on the explosive profit potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them directly.

See 4 crypto-related stocks now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

PetMed Express, Inc. (PETS): Free Stock Analysis Report

PerkinElmer, Inc. (PKI): Free Stock Analysis Report

Becton, Dickinson and Company (BDX): Free Stock Analysis Report

GNC Holdings, Inc. (GNC): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics

Earnings Stocks

Latest Markets Videos


    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

    Learn More